Myth Spotlight:
GLP-1 meds like Ozempic mess with your Botox results.
Cue the panic in aesthetic WhatsApp groups and Facebook forums:
“I’ve got patients losing weight, looking like deflated balloons, and now
they’re blaming me for their Botox fading faster.
Classic. Blame the injector, not the metabolism.
Reality Check:
No, Ozempic doesn’t directly cancel out your Botox. The GLP-1 agonists (semaglutide, liraglutide, etc.) work on the pancreas and gut, not the neuromuscular junction. Botox still blocks acetylcholine, and skinny jabs don’t magically unblock it. So technically, the duration remains the same. BUT. (There’s always a “but”, isn’t there?)
Here’s what’s actually changing:
Patients on semaglutide lose fat everywhere, including the face. Suddenly, Your Botox-treated muscles are more visible and more mobile, not because The toxin wore off, but because the facial fat hiding movement is gone. Ozempic Face is real.
Less subcutaneous fat = harsher angles = “Why do I look older after losing weight?
Faster metabolism? Maybe. Some argue that an increased metabolic rate could theoretically speed up toxin breakdown. But we’re in murky waters. The research isn’t there—yet.
Truth Bomb:
You’re not fighting Botox resistance. You’re fighting the law of facial volume physics.
So no, don’t panic. But DO:
Adjust your Botox plan for changing facial architecture Be brutally honest with patients: “You wanted less weight—now you’ve got less face.” Combine toxin work with strategic volume replacement. Not filler dumping— placement.
Clinical translation:
Botox + skinny jab = safe combo. Just don’t treat them
the same way you did pre-jab.
